Search
for
Sort by
Research 211–240 of 1000+
- Association between male pattern baldness and prostate disease: A meta-analysis
- Inhibition of 5α-reductase in the rat prostate by Cimicifuga racemosa
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–I
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II
- Efeitos da finasterida sobre culturas de células epiteliais prostáticas normais e tumorais em diferentes sistemas in vitro
- Urological Oncology: Testis Cancer and Advances in Oncological Therapy
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?
- 409 ANDROGEN RECEPTOR GENE POLYMORPHISM (SNP RS6152) – ITS RELATIONSHIP TO ANDROGEN-SENSITIVE GENES EXPRESSION IN BENIGN PROSTATIC HYPERPLASIA, CARCINOMA OF THE PROSTATE AND ANDROGENETIC ALOPECIA
- Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted <sup>99m</sup>Tc-Radioimaging Agents
- 5α‐Reductase Isozymes and Androgen Actions in the Prostate
- Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial
- The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
- Association of Spironolactone Use With Risk of Cancer
- Cancer risk by the subtype of alopecia
- Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient
- Steroidogenesis in steroid related cancers
- Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata
- Reply to: a rare case of vulvar skin metastasis of rectal cancer after operation
- Incidence of alopecia from endocrine therapies in cancer
- S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8)
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Male alopecia, finasteride, and cancer risk
- NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)